HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D R Tatulashvili Selected Research

Acetyldigoxins

3/2000[A disorder of myocardial contractile function in acute experimental coronary failure: the submolecular mechanisms and the action of cardiac glycosides].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D R Tatulashvili Research Topics

Disease

2Myocardial Infarction
01/2002 - 12/2001
1Ischemia
11/2005
1Asthma (Bronchial Asthma)
06/2005
1Infarction (Infarctions)
09/2002
1Coronary Occlusion
01/2002
1Heart Failure
03/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
03/2000

Drug/Important Bio-Agent (IBA)

2energostimIBA
09/2002 - 12/2001
1Fluorescent Dyes (Fluorescent Probes)IBA
11/2005
1Peptides (Polypeptides)IBA
06/2005
1Vasoconstrictor AgentsIBA
06/2005
1Endothelin-1 (Endothelin 1)IBA
06/2005
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2002
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2002
1Therapeutic UsesIBA
01/2002
1EnzymesIBA
12/2001
1Creatine Kinase (Creatine Phosphokinase)IBA
12/2001
1Coenzymes (Enzyme Cofactors)IBA
12/2001
1pyridineIBA
12/2001
1NAD (NADH)IBA
12/2001
1Niacinamide (Nicotinamide)FDA LinkGeneric
12/2001
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2001
1NucleotidesIBA
12/2001
1Cytochromes c (Cytochrome c)IBA
12/2001
1Dopamine (Intropin)FDA LinkGeneric
12/2001
1Epinephrine (Adrenaline)FDA LinkGeneric
12/2001
1Contractile ProteinsIBA
03/2000
1strophanthin KIBA
03/2000
1Adenosine Triphosphate (ATP)IBA
03/2000
1Medigoxin (Metildigoxin)IBA
03/2000
1Cardiac GlycosidesIBA
03/2000
1ActomyosinIBA
03/2000
1AcetyldigoxinsIBA
03/2000

Therapy/Procedure

3Therapeutics
06/2005 - 01/2002